Tratamientos que no producen la eliminacin linftica medible y la reduccin de circunferencia que indican una eliminacin eficaz de grasa, dejando subproductos metablicos en el tejido
The problem for GLP-1 users is that almost nothing you actually need comes at low doses
Comprehensive toxicology studies found no lethal dose even at extremely high levels (20 mg/kg intramuscularly in rats, equivalent to approximately 1,400 mg for a 155 pound human)
The capsule formulation is designed for research examining the peptides activity when administered through the gastrointestinal route
The decision to continue, adjust, or discontinue therapy should be based on objective body composition measurements (DEXA scans, circumference measurements), achievement of fat loss goals, tolerance and side effect profile, and physician assessment of metabolic markers
and Hofmann E